{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T01:48:04Z","timestamp":1760320084086,"version":"3.40.3"},"publisher-location":"Berlin, Heidelberg","reference-count":66,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642201943"},{"type":"electronic","value":"9783642201950"}],"license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-3-642-20195-0_9","type":"book-chapter","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T07:13:32Z","timestamp":1314774812000},"page":"181-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Small Sample Approach, and Statistical and Epidemiological Aspects"],"prefix":"10.1007","author":[{"given":"Martin","family":"Offringa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanneke","family":"van der Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,5]]},"reference":[{"key":"9_CR1_9","unstructured":"(2004) PEST 4.4 operating manual. The University of Reading, Reading"},{"key":"9_CR2_9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1214\/aoms\/1177705996","volume":"31","author":"TW Anderson","year":"1960","unstructured":"Anderson TW (1960) A modification of the sequential probability ratio test to reduce the sample size. Ann Math Stat 31:165\u2013197","journal-title":"Ann Math Stat"},{"key":"9_CR3_9","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.2105\/AJPH.48.10.1395","volume":"48","author":"P Armitage","year":"1958","unstructured":"Armitage P (1958) Sequential methods in clinical trials. Am J Public Health 48:1395\u20131402","journal-title":"Am J Public Health"},{"key":"9_CR4_9","volume-title":"Sequential medical trials","author":"P Armitage","year":"1975","unstructured":"Armitage P (1975) Sequential medical trials. Blackwell, Oxford"},{"key":"9_CR5_9","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1001\/jama.2010.310","volume":"303","author":"D Bassler","year":"2010","unstructured":"Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH, Flynn DN, Elamin MB, Murad MH, Abu Elnour NO, Lampropulos JF, Sood A, Mullan RJ, Erwin PJ, Bankhead CR, Perera R, Ruiz CC, You JJ, Mulla SM, Kaur J, Nerenberg KA, Schunemann H, Cook DJ, Lutz K, Ribic CM, Vale N, Malaga G, Akl EA, Ferreira-Gonzalez I, Alonso-Coello P, Urrutia G, Kunz R, Bucher HC, Nordmann AJ, Raatz H, da Silva SA, Tuche F, Strahm B, Djulbegovic B, Adhikari NK, Mills EJ, Gwadry-Sridhar F, Kirpalani H, Soares HP, Karanicolas PJ, Burns KE, Vandvik PO, Coto-Yglesias F, Chrispim PP, Ramsay T (2010) Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 303:1180\u20131187","journal-title":"JAMA"},{"key":"9_CR6_9","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/(SICI)1097-0258(19990730)18:14<1833::AID-SIM221>3.0.CO;2-3","volume":"18","author":"P Bauer","year":"1999","unstructured":"Bauer P, Kieser M (1999) Combining different phases in the development of medical treatments within a single trial. Stat Med 18:1833\u20131848","journal-title":"Stat Med"},{"key":"9_CR7_9","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2307\/2533441","volume":"50","author":"P Bauer","year":"1994","unstructured":"Bauer P, Kohne K (1994) Evaluation of experiments with adaptive interim analyses. Biometrics 50:1029\u20131041","journal-title":"Biometrics"},{"key":"9_CR8_9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0009-9236(97)90170-3","volume":"61","author":"E Bellissant","year":"1997","unstructured":"Bellissant E, Duhamel JF, Guillot M, Pariente-Khayat A, Olive G, Pons G (1997) The triangular test to assess the efficacy of metoclopramide in gastroesophageal reflux. Clin Pharmacol Ther 61:377\u2013384","journal-title":"Clin Pharmacol Ther"},{"key":"9_CR9_9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.clinthera.2010.02.011","volume":"32","author":"SW Boellner","year":"2010","unstructured":"Boellner SW, Stark JG, Krishnan S, Zhang Y (2010) Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit\/hyperactivity disorder: a single-dose, randomized, open-label, crossover study. Clin Ther 32:252\u2013264","journal-title":"Clin Ther"},{"key":"9_CR10_9","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/sim.3538","volume":"28","author":"F Bretz","year":"2009","unstructured":"Bretz F, Koenig F, Brannath W, Glimm E, Posch M (2009) Adaptive designs for confirmatory clinical trials. Stat Med 28:1181\u20131217","journal-title":"Stat Med"},{"key":"9_CR11_9","volume-title":"Guideline on clinical trials in small populations","author":"CHMP","year":"2006","unstructured":"CHMP (2006a) Guideline on clinical trials in small populations. EMA, London"},{"key":"9_CR12_9","volume-title":"Reflection paper on methodological issues in confirmatory clinical trials with flexible design and analysis plan","author":"CHMP","year":"2006","unstructured":"CHMP (2006b) Reflection paper on methodological issues in confirmatory clinical trials with flexible design and analysis plan. EMA, London"},{"key":"9_CR13_9","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/sim.2051","volume":"24","author":"DS Coad","year":"2005","unstructured":"Coad DS, Ivanova A (2005) The use of the triangular test with response-adaptive treatment allocation. Stat Med 24:1483\u20131493","journal-title":"Stat Med"},{"key":"9_CR14_9","volume-title":"EaSt: a software package for the design and interim monitoring of group sequential clinical trials","author":"Cytel Software Corporation","year":"1992","unstructured":"Cytel Software Corporation (1992) EaSt: a software package for the design and interim monitoring of group sequential clinical trials. Cytel Software Corporation, Cambridge, MA"},{"key":"9_CR15_9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00228-009-0782-9","volume":"1","author":"RF Cock","year":"2011","unstructured":"De Cock RF, Piana C, Krekels EH, Danhof M, Allegaert K, Knibbe CA (2011) The role of population PK-PD modelling in paediatric clinical research. Eur J Clin Pharmacol. 67 Suppl 1:5\u201316","journal-title":"Eur J Clin Pharmacol. 67 Suppl"},{"key":"9_CR16_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta2150","volume":"2","author":"SJ Edwards","year":"1998","unstructured":"Edwards SJ, Lilford RJ, Braunholtz DA, Jackson JC, Hewison J, Thornton J (1998) Ethical issues in the design and conduct of randomised controlled trials. Health Technol Assess 2:1\u2013132","journal-title":"Health Technol Assess"},{"key":"9_CR66_9","doi-asserted-by":"publisher","DOI":"10.1002\/0470854162","volume-title":"Data Monitoring Committees in Clinical Trials","author":"SS Ellenberg","year":"2002","unstructured":"Ellenberg SS, Fleming TR, DeMets DL (2002) Data Monitoring Committees in Clinical Trials. Chichester, John Wiley Sons, Ltd"},{"key":"9_CR17_9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2307\/2531692","volume":"45","author":"SS Emerson","year":"1989","unstructured":"Emerson SS, Fleming TR (1989) Symmetric group sequential test designs. Biometrics 45:905\u2013923","journal-title":"Biometrics"},{"key":"9_CR18_9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2431-9-77","volume":"9","author":"RM Fernandes","year":"2009","unstructured":"Fernandes RM, van der Lee JH, Offringa M (2009) A systematic review of the reporting of Data Monitoring Committees\u2019 roles, interim analysis and early termination in pediatric clinical trials. BMC Pediatr 9:77","journal-title":"BMC Pediatr"},{"key":"9_CR19_9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1034\/j.1399-3046.2003.00015.x","volume":"7","author":"G Filler","year":"2003","unstructured":"Filler G, Browne R, Seikaly MG (2003) Glomerular filtration rate as a putative \u2018surrogate end-point\u2019 for renal transplant clinical trials in children. Pediatr Transplant 7:18\u201324","journal-title":"Pediatr Transplant"},{"key":"9_CR20_9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1056\/NEJM197809282991304","volume":"299","author":"JA Freiman","year":"1978","unstructured":"Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR (1978) The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 \u201cnegative\u201d trials. N Engl J Med 299:690\u2013694","journal-title":"N Engl J Med"},{"key":"9_CR21_9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/bmj.39070.527986.68","volume":"334","author":"P Glasziou","year":"2007","unstructured":"Glasziou P, Chalmers I, Rawlins M, McCulloch P (2007) When are randomised trials unnecessary? Picking signal from noise. BMJ 334:349\u2013351","journal-title":"BMJ"},{"key":"9_CR22_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9070","volume":"9","author":"AM Grant","year":"2005","unstructured":"Grant AM, Altman DG, Babiker AB, Campbell MK, Clemens FJ, Darbyshire JH, Elbourne DR, McLeer SK, Parmar MK, Pocock SJ, Spiegelhalter DJ, Sydes MR, Walker AE, Wallace SA (2005) Issues in data monitoring and interim analysis of trials. Health Technol Assess 9:1\u2013238","journal-title":"Health Technol Assess"},{"key":"9_CR23_9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1259\/0007-1285-44-526-793","volume":"44","author":"JL Haybittle","year":"1971","unstructured":"Haybittle JL (1971) Repeated assessment of results in clinical trials of cancer treatment. Br J Radiol 44:793\u2013797","journal-title":"Br J Radiol"},{"key":"9_CR24_9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.pediatrneurol.2005.09.011","volume":"34","author":"DG Hirtz","year":"2006","unstructured":"Hirtz DG, Gilbert PR, Terrill CM, Buckman SY (2006) Clinical trials in children \u2013 how are they implemented? Pediatr Neurol 34:436\u2013438","journal-title":"Pediatr Neurol"},{"key":"9_CR25_9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/1521-4036(200109)43:5<581::AID-BIMJ581>3.0.CO;2-J","volume":"43","author":"G Hommel","year":"2001","unstructured":"Hommel G (2001) Adaptive modifications of hypotheses after an interim analysis. Biometrical J 43:581\u2013589","journal-title":"Biometrical J"},{"key":"9_CR26_9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/sim.1457","volume":"22","author":"C Jennison","year":"2003","unstructured":"Jennison C, Turnbull BW (2003) Mid-course sample size modification in clinical trials based on the observed treatment effect. Stat Med 22:971\u2013993","journal-title":"Stat Med"},{"key":"9_CR27_9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1081\/BIP-200062857","volume":"15","author":"PJ Kelly","year":"2005","unstructured":"Kelly PJ, Stallard N, Todd S (2005) An adaptive group sequential design for phase II\/III clinical trials that select a single treatment from several. J Biopharm Stat 15:641\u2013658","journal-title":"J Biopharm Stat"},{"key":"9_CR28_9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/(SICI)1521-4036(199906)41:3<261::AID-BIMJ261>3.0.CO;2-U","volume":"41","author":"M Kieser","year":"1999","unstructured":"Kieser M, Bauer P, Lehmacher W (1999) Inference on multiple endpoints in clinical trials with adaptive interim analyses. Biometrical J 41:261\u2013277","journal-title":"Biometrical J"},{"key":"9_CR29_9","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/S0140-6736(09)61803-1","volume":"374","author":"TP Klassen","year":"2009","unstructured":"Klassen TP, Hartling L, Hamm M, van der Lee JH, Ursum J, Offringa M (2009) StaR Child Health: an initiative for RCTs in children. Lancet 374:1310\u20131312","journal-title":"Lancet"},{"key":"9_CR30_9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0895-4356(00)00276-6","volume":"54","author":"JA Knottnerus","year":"2001","unstructured":"Knottnerus JA, Bouter LM (2001) The ethics of sample size: two-sided testing and one-sided thinking. J Clin Epidemiol 54:109\u2013110","journal-title":"J Clin Epidemiol"},{"key":"9_CR31_9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2307\/2336502","volume":"70","author":"KKG Lan","year":"1983","unstructured":"Lan KKG, DeMets DL (1983) Discrete sequential boundaries for clinical trials. Biometrika 70:659\u2013663","journal-title":"Biometrika"},{"key":"9_CR32_9","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/j.0006-341X.1999.01286.x","volume":"55","author":"W Lehmacher","year":"1999","unstructured":"Lehmacher W, Wassmer G (1999) Adaptive sample size calculations in group sequential trials. Biometrics 55:1286\u20131290","journal-title":"Biometrics"},{"key":"9_CR33_9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0022-3476(98)70057-5","volume":"133","author":"RE McKinney Jr","year":"1998","unstructured":"McKinney RE Jr, Johnson GM, Stanley K, Yong FH, Keller A, O\u2019Donnell KJ, Brouwers P, Mitchell WG, Yogev R, Wara DW, Wiznia A, Mofenson L, McNamara J, Spector SA (1998) A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team. J Pediatr 133:500\u2013508","journal-title":"J Pediatr"},{"key":"9_CR34_9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0895-4356(01)00458-9","volume":"55","author":"LA Moye","year":"2002","unstructured":"Moye LA, Tita AT (2002) Hypothesis testing complexity in the name of ethics: response to commentary. J Clin Epidemiol 55:209\u2013211","journal-title":"J Clin Epidemiol"},{"key":"9_CR35_9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/bja\/ael187","volume":"97","author":"Y Nyman","year":"2006","unstructured":"Nyman Y, Von HK, Palm C, Eksborg S, Lonnqvist PA (2006) Etomidate-Lipuro is associated with considerably less injection pain in children compared with propofol with added lidocaine. Br J Anaesth 97:536\u2013539","journal-title":"Br J Anaesth"},{"key":"9_CR36_9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2307\/2530245","volume":"35","author":"PC O\u2019Brien","year":"1979","unstructured":"O\u2019Brien PC, Fleming TR (1979) A multiple testing procedure for clinical trials. Biometrics 35:549\u2013556","journal-title":"Biometrics"},{"key":"9_CR37_9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00228-008-0493-7","volume":"64","author":"K Ogungbenro","year":"2008","unstructured":"Ogungbenro K, Aarons L (2008) How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approach. Eur J Clin Pharmacol 64:705\u2013713","journal-title":"Eur J Clin Pharmacol"},{"key":"9_CR38_9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0378-3758(94)90187-2","volume":"42","author":"S Pampallona","year":"1994","unstructured":"Pampallona S, Tsiatis AA (1994) Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis. J Stat Plan Infer 42:19\u201335","journal-title":"J Stat Plan Infer"},{"key":"9_CR39_9","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/bmj.317.7167.1170","volume":"317","author":"R Peto","year":"1998","unstructured":"Peto R, Baigent C (1998) Trials: the next 50 years. Large scale randomised evidence of moderate benefits. BMJ 317:1170\u20131171","journal-title":"BMJ"},{"key":"9_CR40_9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/biomet\/64.2.191","volume":"64","author":"SJ Pocock","year":"1977","unstructured":"Pocock SJ (1977) Group sequential methods in the design and analysis of clinical trials. Biometrika 64:191\u2013199","journal-title":"Biometrika"},{"key":"9_CR41_9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1191\/1740774504cn016oa","volume":"1","author":"WF Rosenberger","year":"2004","unstructured":"Rosenberger WF, Huc F (2004) Maximizing power and minimizing treatment failures in clinical trials. Clin Trials 1:141\u2013147","journal-title":"Clin Trials"},{"key":"9_CR42_9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1749-6632.1993.tb26331.x","volume":"703","author":"DL Sackett","year":"1993","unstructured":"Sackett DL, Cook DJ (1993) Can we learn anything from small trials? Ann NY Acad Sci 703:25\u201331","journal-title":"Ann NY Acad Sci"},{"key":"9_CR43_9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/adc.2010.203737","volume":"96","author":"HM Sammons","year":"2011","unstructured":"Sammons HM (2011) Avoiding clinical trials in children. Arch Dis Child 96:291\u2013292","journal-title":"Arch Dis Child"},{"key":"9_CR44_9","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(05)61034-3","volume":"365","author":"KF Schulz","year":"2005","unstructured":"Schulz KF, Grimes DA (2005) Sample size calculations in randomised trials: mandatory and mystical. Lancet 365:1348\u20131353","journal-title":"Lancet"},{"key":"9_CR45_9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1042\/CS19990336","volume":"98","author":"V Sebille","year":"2000","unstructured":"Sebille V, Bellissant E (2000) Comparison of four sequential methods allowing for early stopping of comparative clinical trials. Clin Sci (Lond) 98:569\u2013578","journal-title":"Clin Sci (Lond)"},{"key":"9_CR46_9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1472-8206.2003.00192.x","volume":"17","author":"V Sebille","year":"2003","unstructured":"Sebille V, Bellissant E (2003) Sequential methods and group sequential designs for comparative clinical trials. Fundam Clin Pharmacol 17:505\u2013516","journal-title":"Fundam Clin Pharmacol"},{"key":"9_CR47_9","doi-asserted-by":"publisher","first-page":"122C","DOI":"10.1016\/S0002-9149(99)80482-2","volume":"76","author":"RJ Simes","year":"1995","unstructured":"Simes RJ (1995) Prospective meta-analysis of cholesterol-lowering studies: the Prospective Pravastatin Pooling (PPP) Project and the Cholesterol Treatment Trialists (CTT) Collaboration. Am J Cardiol 76:122C\u2013126C","journal-title":"Am J Cardiol"},{"key":"9_CR48_9","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1136\/bmj.327.7429.1459","volume":"327","author":"GC Smith","year":"2003","unstructured":"Smith GC, Pell JP (2003) Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 327:1459\u20131461","journal-title":"BMJ"},{"key":"9_CR49_9","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780199231881.001.0001","volume-title":"Health Measurement Scales: a practical guide to their development and use","author":"DL Streiner","year":"2008","unstructured":"Streiner DL, Norman GR (2008) Health Measurement Scales: a practical guide to their development and use. Oxford University Press, Oxford"},{"key":"9_CR50_9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/adc.80.3.210","volume":"80","author":"WO Tarnow-Mordi","year":"1999","unstructured":"Tarnow-Mordi WO, Healy MJ (1999) Distinguishing between \u201cno evidence of effect\u201d and \u201cevidence of no effect\u201d in randomised controlled trials and other comparisons. Arch Dis Child 80:210\u2013211","journal-title":"Arch Dis Child"},{"key":"9_CR51_9","volume-title":"Applied longitudinal data analysis for epidemiology; a practical guide","author":"JWR Twisk","year":"2003","unstructured":"Twisk JWR (2003) Applied longitudinal data analysis for epidemiology; a practical guide. Cambridge University Press, Cambridge"},{"key":"9_CR52_9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jclinepi.2007.07.008","volume":"61","author":"JH van der Lee","year":"2008","unstructured":"van der Lee JH, Wesseling J, Tanck MW, Offringa M (2008) Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases. J Clin Epidemiol 61:324\u2013330","journal-title":"J Clin Epidemiol"},{"key":"9_CR53_9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1651-2227.2009.01249.x","volume":"98","author":"JH van der Lee","year":"2009","unstructured":"van der Lee JH, Tanck MW, Wesseling J, Offringa M (2009) Pitfalls in the design and analysis of paediatric clinical trials: a case of a \u2018failed\u2019 multi-centre study, and potential solutions. Acta Paediatr 98:385\u2013391","journal-title":"Acta Paediatr"},{"key":"9_CR54_9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jclinepi.2009.07.005","volume":"63","author":"JH van der Lee","year":"2010","unstructured":"van der Lee JH, Wesseling J, Tanck MW, Offringa M (2010) Sequential design with boundaries approach in pediatric intervention research reduces sample size. J Clin Epidemiol 63:19\u201327","journal-title":"J Clin Epidemiol"},{"key":"9_CR55_9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0895-4356(99)00064-5","volume":"52","author":"HC van Houwelingen","year":"1999","unstructured":"van Houwelingen HC (1999) On \u201cBayesian monitoring\u2026\u201d. J Clin Epidemiol 52:713\u2013714","journal-title":"J Clin Epidemiol"},{"key":"9_CR56_9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/thorax.58.5.383","volume":"58","author":"JB van Woensel","year":"2003","unstructured":"van Woensel JB, van Aalderen WM, de Weerd W, Jansen NJ, van Gestel JP, Markhorst DG, van Vught AJ, Bos AP, Kimpen JL (2003) Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax 58:383\u2013387","journal-title":"Thorax"},{"key":"9_CR57_9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0895-4356(03)00141-0","volume":"56","author":"AJ Vickers","year":"2003","unstructured":"Vickers AJ (2003) Underpowering in randomized trials reporting a sample size calculation. J Clin Epidemiol 56:717\u2013720","journal-title":"J Clin Epidemiol"},{"key":"9_CR58_9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/bmj.323.7321.1123","volume":"323","author":"AJ Vickers","year":"2001","unstructured":"Vickers AJ, Altman DG (2001) Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ 323:1123\u20131124","journal-title":"BMJ"},{"key":"9_CR59_9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1213\/01.ANE.0000143563.39519.FD","volume":"100","author":"A von Goedecke","year":"2005","unstructured":"von Goedecke A, Brimacombe J, Hormann C, Jeske HC, Kleinsasser A, Keller C (2005) Pressure support ventilation versus continuous positive airway pressure ventilation with the ProSeal laryngeal mask airway: a randomized crossover study of anesthetized pediatric patients. Anesth Analg 100:357\u2013360","journal-title":"Anesth Analg"},{"key":"9_CR60_9","volume-title":"Sequential analysis","author":"A Wald","year":"1947","unstructured":"Wald A (1947) Sequential analysis. Wiley, New York"},{"key":"9_CR61_9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF02925923","volume":"41","author":"G Wassmer","year":"2000","unstructured":"Wassmer G (2000) Basic concepts of group sequential and adaptive group sequential test procedures. Stat Pap 41:253\u2013279","journal-title":"Stat Pap"},{"key":"9_CR62_9","volume-title":"The design and analysis of sequential clinical trials","author":"J Whitehead","year":"1997","unstructured":"Whitehead J (1997) The design and analysis of sequential clinical trials. Wiley, Chichester"},{"key":"9_CR63_9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/biomet\/66.3.443","volume":"66","author":"J Whitehead","year":"1979","unstructured":"Whitehead J, Jones DR (1979) The analysis of sequential clinical trials. Biometrika 66:443\u2013452","journal-title":"Biometrika"},{"key":"9_CR64_9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2307\/2530822","volume":"39","author":"J Whitehead","year":"1983","unstructured":"Whitehead J, Stratton I (1983) Group sequential clincial trials with triangular continuation regions. Biometrics 39:227\u2013236","journal-title":"Biometrics"},{"key":"9_CR65_9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-110-7-560","volume":"110","author":"JR Woods","year":"1989","unstructured":"Woods JR, Williams JG, Tavel M (1989) The two-period crossover design in medical research. Ann Intern Med 110:560\u2013566","journal-title":"Ann Intern Med"}],"container-title":["Handbook of Experimental Pharmacology","Pediatric Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-20195-0_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T13:55:25Z","timestamp":1706190925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-20195-0_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9783642201943","9783642201950"],"references-count":66,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-20195-0_9","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"type":"print","value":"0171-2004"},{"type":"electronic","value":"1865-0325"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"5 July 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}